No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Alleles
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / immunology
-
Dexamethasone / administration & dosage
-
Drug Eruptions / diagnosis
-
Drug Eruptions / etiology*
-
Drug Eruptions / immunology
-
Female
-
HLA-A Antigens / analysis
-
HLA-B Antigens / analysis
-
HLA-C Antigens / analysis
-
HLA-DQ beta-Chains / genetics*
-
HLA-DRB1 Chains / genetics*
-
Humans
-
Italy
-
Lenalidomide
-
Male
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / genetics
-
Multiple Myeloma / immunology*
-
Prednisolone / administration & dosage
-
Severity of Illness Index
-
Thalidomide / administration & dosage
-
Thalidomide / adverse effects
-
Thalidomide / analogs & derivatives*
-
Thalidomide / immunology
-
White People / genetics
Substances
-
Antineoplastic Agents
-
HLA-A Antigens
-
HLA-B Antigens
-
HLA-C Antigens
-
HLA-DQ beta-Chains
-
HLA-DQB1 antigen
-
HLA-DRB1 Chains
-
HLA-DRB1*15:01 antigen
-
Thalidomide
-
Dexamethasone
-
Prednisolone
-
Lenalidomide